CD4 and neoplasm: These patients also had a significant decrease of lymphocytes and increased numbers of functionally suppressive CD4+CD25+ Tregs in the peripheral blood and tumor microenvironment, With a subsequent increase of CTLA4 expression on both T cells and breast cancer cells [21–23].